Invo Bioscience (IVOB) Announces Earnings Results

Invo Bioscience (OTCMKTS:IVOB) announced its quarterly earnings results on Tuesday. The company reported ($0.01) earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The business had revenue of $0.11 million during the quarter.

IVOB opened at $0.49 on Thursday. Invo Bioscience has a one year low of $0.08 and a one year high of $0.77. The company has a quick ratio of 0.04, a current ratio of 0.05 and a debt-to-equity ratio of -0.03.

About Invo Bioscience

INVO Bioscience, Inc provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development.

Read More: Understanding Relative Strength Index

Receive News & Ratings for Invo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply